To help hone its AI system — called Mastermind — Genomenon last month acquired contract genomics company Boston Genetics, a longtime science partner of theirs. The goal is to improve curation of their human genome database to help pharma companies and researchers review past studies more thoroughly and quickly.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,